PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Metformin trial dramatically reduces seizures in tuberous sclerosis

2021-03-29
(Press-News.org) A team of researchers led by UCL Great Ormond Street Institute of Child Health (ICH) and Great Ormond Street Hospital (GOSH) has found that metformin - a drug commonly used to treat Type 2 diabetes - can successfully reduce symptoms associated with tuberous sclerosis complex (TSC), including reduction in the frequency of seizures and the size of brain tumours.

The study, which also included teams from Royal United Hospitals Bath NHS Foundation Trust (RUH) and University Hospitals Bristol and Weston NHS Foundation Trust, recruited 51 patients with TSC who were randomly assigned a placebo or metformin for one year on a dose similar to that given for Type 2 diabetes.

TSC is a genetic disorder characterised by the development of benign tumours due to loss of inhibitory regulation of the mTOR (mechanistic Target of Rapamycin) intracellular growth pathway. As a result, people with the condition may develop tumours (hamartomas) throughout the body that can affect the heart, kidneys, brain, skin and nails. Although some with the condition may experience few issues, for others it can be disfiguring or even have life threatening complications. As tumours can form in the brain, 75% of people with TSC will have epilepsy, which can lead to daily seizures.

Throughout the study, the research team wanted to see if metformin, which inhibits the mTOR (cellular growth) pathway, could limit the tumour growth and epilepsy associated with TSC. All patients involved in the study had tumours in the kidney known as renal angiomyolipomas (AML). Of the 51 who took part, 27 patients had tumours in the brain called subependymal giant cell astrocytomas (SEGA) and 21 of them were under assessment for seizure frequency.

Over the course of the year, the team found a 21% reduction in the size of brain tumours of those who were given metformin, compared to a 3% increase in tumour volume for those taking the placebo. Patients with epilepsy and taking metformin saw a 44% drop in the frequency of their seizures, compared to a drop of only 3% for those on the placebo.

Metformin has been gaining attention in cancer research, with large population studies starting to show reduced rates of cancers in those regularly taking it. Metformin is also used to treat polycystic ovary syndrome.

Finbar O'Callaghan, professor of paediatric neuroscience at ICH and consultant paediatric neurologist at Great Ormond Street Hospital for Children NHS Foundation Trust and lead investigator of the study said: "This is the first time a cheap, readily available, safe drug has been found to improve the symptoms of TSC. And we found metformin to be even more effective in treating young people. Some patients, who were having multiple seizures a day or week became seizure free after 12 months of treatment, while others are having far fewer seizures than before. We're excited by what this could mean for the day-to day management of tuberous sclerosis patients." After 12 months of studying patients involved in the trial, the only area where researchers saw no significant difference between the metformin and placebo group was in the reduction of kidney tumours. Previous animal studies have also indicated limited effects of metformin in the kidney.

"Unfortunately, the dose of metformin we used wasn't able to treat the kidney tumours our patients have, but we are looking into whether changing the dose could make a difference. We remain optimistic about the impact we've seen on the treatment of brain tumours and epileptic seizures, and believe this is a very promising step forward in improving quality of life for the children and adults living with TSC," said Prof. O'Callaghan.

It is estimated that between 3,700 - 11,000 people in the UK live with TSC. There is currently no cure, and only its symptoms can be treated with regular monitoring by a specialist doctor. Although the tumours in TSC patients are benign, the symptoms are not, and current treatments are not only expensive but have toxic side effects as they are immunosuppressants. That's why studies like this are significant.

GOSH treats 150 children with this condition and works closely with the two other hospitals with specialist TSC services that enrolled patients. The study team run specialist TS clinics at Great Ormond Street Hospital, the Royal United Hospital in Bath, and Bristol Royal Hospital for Children. These clinics follow up the largest number of TSC patients in the UK.

Speaking about future research in the area this Prof. O'Callaghan said: "Next steps for this work will be to conduct further large-scale trials in Tuberous sclerosis patients to determine the best doses to use and to demonstrate that the effect we have seen is repeatable in a larger population of patients."

INFORMATION:

All research at GOSH is underpinned by support from the NIHR Great Ormond Street Hospital Biomedical Research Centre.

About Great Ormond Street Hospital for Children NHS Foundation Trust.

Founded in 1852, Great Ormond Street Hospital is one of the world's leading children's hospitals with the broadest range of dedicated, children's healthcare specialists under one roof in the UK. With more than 252,000 outpatient and 43,000 inpatient visits every year, the hospital's pioneering research and treatment gives hope to children from across the UK with the rarest, most complex and often life-threatening conditions. As an international centre of excellence in child healthcare, our patients and families are central to everything we do - from the moment they come through the door and for as long as they need us.

About the UCL Great Ormond Street Institute of Child Health (ICH) The UCL Great Ormond Street Institute of Child Health (ICH) is part of the Faculty of Population Health Sciences within the School of Life and Medical Sciences at University College London. Together with its clinical partner Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH), it forms the UK's only paediatric National Institute for Health Research Biomedical Research Centre and has the largest concentration of children's health research in Europe. For more information visit http://www.ucl.ac.uk/ich



ELSE PRESS RELEASES FROM THIS DATE:

First detailed look at crucial enzyme advances cancer research

First detailed look at crucial enzyme advances cancer research
2021-03-29
In order to develop more effective drugs against a range of cancers, researchers have been investigating the molecular structure of many diseased-linked enzymes in the body. An intriguing case in point is Taspase 1, a type of enzyme known as a protease. The primary duty of proteases is to break down proteins into smaller peptide snippets or single amino acids. Taspase 1 appears to play a vital role in a range of physiological processes, including cell metabolism, proliferation, migration and termination. The normal functioning of Taspase 1 can go awry however, leading to a range of diseases, including leukemia, colon and breast cancers, as well as glioblastoma, a particularly lethal and incurable malignancy in the brain. Because Taspase 1 dysregulation is increasingly ...

Drug coupons and vouchers cover only a sliver of prescription drugs

2021-03-29
Use of vouchers and coupons offered by pharmaceutical companies to defray patients' out-of-pocket drug costs is concentrated among a small number of drugs. While these offsets significantly reduce patient costs, they are not targeted to patients who most need the price reduction, according to a study from researchers at the Johns Hopkins Bloomberg School of Public Health. The researchers, in what is thought to be the largest study of its kind to date, analyzed tens of millions of pharmacy transactions by more than 600,000 people in the U.S. during 2017-19, in order to get a better sense of how vouchers and other point-of-sale copayment "offsets" are used. These coupons and vouchers come in many forms--some are offered online directly to customers, others by pharmacy ...

NIST develops privacy-preserving 'encounter metrics' that could slow down future pandemics

NIST develops privacy-preserving encounter metrics that could slow down future pandemics
2021-03-29
When you bump into someone in the workplace or at your local coffee shop, you might call that an "encounter." That's the scientific term for it, too. As part of urgent efforts to fight COVID-19, a science is rapidly developing for measuring the number of encounters and the different levels of interaction in a group. At the National Institute of Standards and Technology (NIST), researchers are applying that science to a concept they have created called "encounter metrics." They have developed an encrypted method that can be applied to a device such as your phone to help with the ultimate goal of slowing down or preventing future pandemics. The method is also applicable to the COVID-19 pandemic. Their research ...

How cells transport molecules with 'active carpets'

How cells transport molecules with active carpets
2021-03-29
A drop of food coloring slowly spreading in a glass of water is driven by a process known as diffusion. While the mathematics of diffusion have been known for many years, how this process works in living organisms is not as well understood. Now, a study published in Nature Communications provides new insights on the process of diffusion in complex systems. The result of a collaboration between physicists at Penn, the University of Chile, and Heinrich Heine University Düsseldorf, this new theoretical framework has broad implications for active surfaces, such as ones found in biofilms, active coatings, and even mechanisms for pathogen clearance. Diffusion is described ...

Mental health support at schools helps male, but not female, students feel safe from bullying

2021-03-29
BUFFALO, N.Y. - Bullying at boarding schools has a negative impact on students' emotional health, but for male students, having a school staff member to rely on for support may mute the harmful effects of bullying, according to a new University at Buffalo study. Support networks did not have the same effect for female students, the researchers say. The study, recently published in School Psychology Review, is one of few to examine the impact of bullying at boarding schools, which provide a unique environment where most students live on school grounds, away from their families. It is also one of the first studies to observe the effects ...

Carbon labeling reduces our CO2 footprint -- even for those who try to remain uninformed

2021-03-29
Climate labels informing us of a meat product's carbon footprint cause many people to opt for climate-friendlier alternatives. This applies to people who are curious about a product's carbon footprint, as well as to those who actively avoid wanting to know more. The finding is published in a new study from, among others, the University of Copenhagen. As such, climate labeling food products can be a good way of reducing our climate footprint. But according to the researcher behind the study, labels must be obligatory for them to be effective. Certain situations exist where we humans strategically avoid greater knowledge and more information - a phenomenon known as "active information avoidance". ...

Optogenetics: Light regulates an enzyme

Optogenetics: Light regulates an enzyme
2021-03-29
The unicellular green alga Chlamydomonas reinhardtii has already given research a massive boost: One of its light sensors, channelrhodopsin-2, founded the success of optogenetics about 20 years ago. In this technology, the alga's light sensor is incorporated into cells or small living organisms such as threadworms. Afterwards, certain physiological processes can be triggered or stopped by light. This has already led to several new scientific findings, for example on the function of nerve cells. Now the green alga Chlamydomonas is once again setting an accent. Once again, it is its light sensors, ...

Faster and less-invasive atomic force microscopy for visualizing biomolecular systems

Faster and less-invasive atomic force microscopy for visualizing biomolecular systems
2021-03-29
High-speed atomic force microscopy (HS-AFM) is an imaging technique that can be used for visualizing biological processes, for example the activity of proteins. Nowadays, typical HS-AFM frame rates are as high as 12 frames per second. In order to improve the capabilities of the method, so that it can be applied to an ever expanding range of biological samples, better video rates are needed, though. Moreover, faster recording times imply less interaction between the sample and the probe -- a tip scanning the sample's surface -- making the imaging ...

Astronomy and Landscape in the city of Caral, the oldest city in the Americas

Astronomy and Landscape in the city of Caral, the oldest city in the Americas
2021-03-29
A team of researchers, led by the Instituto de Ciencias del Patrimonio (Incipit-CSIC) and the Instituto de Astrofísica de Canarias (IAC), in collaboration with the team from the Arqueological Zone of Caral (Perú) led by Dr. Ruth Shady Solís, has established the relation between the position of the monuments of the Supe Culture (Perú), their orientations, and some astronomical and topographic features, which opens the way to the analysis of the way the inhabitants of this valley conceived space and time 5000 years ago. The results of the study have just been published in the journal Latin American Antiquity. The valley of the river Supe in Perú contains the first evidence for city building in the Americas. In recent decades in this valley and ...

Deciphering the secrets of printed electronics

Deciphering the secrets of printed electronics
2021-03-29
Next-gen electronics is envisioned to be non-rigid, component-free, flexible, bendable, and easily integrable with different objects. Direct-write printing techniques provide unique opportunity to enable this vision through use of nanomaterial so-called functional inks, that can be tailored to add desired functionalities on various flexible substrates, such as textiles or plastic. The technology, known as Printed Electronics (PE), has been known for decades, but has recently gained considerable attention due to innovation in material inks, process technology and design revolution. To keep the research community abreast with the latest technological advancements in the area of droplet-based PE techniques for next-gen devices, researchers from Aarhus University have now ...

LAST 30 PRESS RELEASES:

Exotic observations with neutrons at the ILL

Scientists discover new gene-to-gene interaction increasing risk of alopecia

Chinese scientists find key genes to fight against crop parasites

Lung cancer cells can go ‘off grid’

An RNA inhibitor may effectively reduce a high-risk type of cholesterol in patients with cardiovascular disease

Research spotlight: Mapping lesions that cause psychosis to a human brain circuit and proposed stimulation target

New study identifies brain region that can prevent aggressive social behavior and induce pro social behavior

Telehealth may be closing the care gap for people with substance use disorder in rural areas

Stronger, safer, smarter: pioneering Zinc-based dissolvable implants for bone repair

Could peripheral neuropathy be stopped before it starts?

China Jurassic fossil discovery sheds light on bird origin

Long-term yogurt consumption tied to decreased incidence of certain types of colorectal cancer

Ovarian cancer discovery could turn failed treatment into lifesaver

DNA methylation clocks may require tissue-specific adjustments for accurate aging estimates

Tidal energy measurements help SwRI scientists understand Titan’s composition, orbital history

Data-driven networks influence convective-scale ensemble weather forecasts

Endocrine Society awards Baxter Prize to innovator in endocrine cancer drug discovery

Companies quietly switching out toxic product ingredients in response to California law

Can math save content creators? A new model proposes fairer revenue distribution methods for streaming services

Study examines grief of zoo employees and volunteers across the US after animal losses

National study underway to test new mechanical heart pump

Antarctica’s only native insect’s unique survival mechanism

How Earth's early cycles shaped the chemistry of life

Ukraine war forces planes to take longer routes, raising CO2

Negative refraction of light using atoms instead of metamaterials

High BP may develop at different ages and paces in East & South Asian adults in the UK

Meet the newly discovered brain cell that allows you to remember objects

Engineered animals show new way to fight mercury pollution

The 3,000-year coral reef shutdown: a mysterious pause and a remarkable recovery

Worm surface chemistry reveals secrets to their development and survival

[Press-News.org] Metformin trial dramatically reduces seizures in tuberous sclerosis